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medial plateaus, iMT) of OA in Japanese.
Methods: Genome-wide DNA methylation analysis was performed
using Illumina Inﬁnium HumanMethylation450 BeadChip array on DNA
extracted from the cartilage of oLT, iLT and iMT region of 8 patients. Raw
IDAT ﬁles were analyzed using package “minﬁ” in R. Data was nor-
malized through SWAN (subquantile normalization) method. Multi-
dimensional scaling (MDS) was used to identify the outliers. Probes that
locate on X/Y chromosomes were removed before applying F test to ﬁnd
out the differential methylated sites of iLT vs oLT and iMT vs oLT. Mul-
tidimensional scaling of the methylation beta values revealed sig-
niﬁcantclusters related to cartilage. F test with p value less than 0.05
and jDbj greater than 0.15 were used to identify the differential
methylated sites. Genes with differentially methylated CpG sites were
analyzed to identify gene ontologies, pathways, and upstream
regulators.
Results: We identiﬁed 310 differentially methylated sites (DMS) cov-
ering 147 genes in comparison of iMT vs. oLT region. Of these, 122(39%)
DMS were hypermethylated and 188 (61%) were hypomethylated.
However, in the comparison of iLT vs. oLT region, we only found 22
differential methylated sites (12 hypermethylated and 10 hypomethy-
lated). The dramatic difference in DMS numbers of iLT and iMT suggests
that methylation is highly involved only at the very late stage of OA. The
DMS we found in iMT cartilage include genes reported related to OA, for
instance, BMP6, COL14A1, NFATC1, and SPOCK1. Enrichment analysis of
the genes with DMS revealed signiﬁcant enrichment of HOX family
genes and development pathways.
Conclusions: In the current study, we have identiﬁed the methylation
changes in both the iLT region and iMT region, which represent the
intermediat and late stage of OA disease. Our data suggested that the
signiﬁcant changes in methylation occurred at during the late stages of
OA. The development pathways and HOX family genes enriched at the
late stage of OA implicated new aspect of cartilage maintenance in
adulthood. The further study of the underlying mechanism may supply
a direction for future cartilage regeneration approaches.
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GENOME-WIDE DNA METHYLATION PROFILING OF OSTEOARTHRITIC
SUBCHONDRAL BONE
Y. Zhang y, N. Fukui z, M. Yahata y, M. Lee y. yRIKEN, Yokohama, Japan;
zUniv. of Tokyo, Tokyo, Japan
Purpose: Osteoarthritis (OA) is a disease of the whole joint organ
involving pathological changes of articular cartilage (AC) and structural
changes of underlying subchondral bone (SB). Several studies looking at
changes in methylation has been performed, but none of them were
performed on the subchondral bone. We previously reported a novel
method for isolating site-matched overlying AC and underlying SB from
regions of interest respectively from the human knee tibial plateau.
Thus, the aim of this study was to characterize the genome-wide DNA
methylation proﬁle from regions representing early (oLT), intermediate
(iLT) and late stage (iMT) of OA in the subchondral bone from knee
joints isolated from arthroplasty in the Japanese population.
Methods: Genome-wide DNA methylation proﬁling was performed
using the Illumina Inﬁnium HumanMethylation450 BeadChip array in
the DNA extracted from the subchondral bone of 8 patients. Raw IDAT
ﬁles were analyzed using the package “minﬁ” in R. Normalization of the
data was performed through the SWAN (subquantile normalization)
method. The outliers were identiﬁed using multidimensional scaling
(MDS). Probes on X/Y chromosomes were removed. F test was used to
determine the differential methylated sites between iLT vs oLT and iMT
vs oLT. Multidimensional scaling of the methylation beta values reveals
signiﬁcant clusters related to subchondral bone. F test with p smaller
than 0.05 and the cutoff threshold of jDbj greater than0.15 were used to
identify the differential methylated sites. Genes with differentially
methylated CpG sites were analyzed to identify gene ontologies, path-
ways, and upstream regulators.
Results: A total of 252 differentially methylated sites (DMS) covering
119 genes in comparison of iMT vs. oLT region. Of these, 114(45%) DMS
were hypermethylated and 138 (55%) were hypomethylated. However,
in the comparison of iLT vs. oLT region, we only found 35 differential
methylated sites (23 hypermethylated and 12 hypomethylated). The
dramatic difference in DMS numbers of iLT and iMT suggests that
methylation is highly involved at the late stage of OA. Enrichmentanalysis of the genes with DMS of iMT vs oLT revealed signiﬁcant
enrichment of HOX family genes, skeletal development and morpho-
genesis pathways, and transcription regulatory pathways, which is
similar to the result from cartilage, but the members of HOX family
genes differ, HOXC genes showed changed methylation status only in
subchondral bone but not cartilage. Genes with DMS of iLT vs oLT
showed enrichment of DNA binding and transcription regulation, but
not HOX or development.
Conclusions: To our best knowledge, this study represents the ﬁrst and
the most comprehensive direct assessment of methylation proﬁling
conducted in OA subchondral bone. With the ability to directly studying
genetic proﬁles of subchondral bone could further the understanding of
the pathogenesis of the disease.
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TRANSTHYRETIN AND AMYLOID IN CARTILAGE AGING AND
OSTEOARTHRITIS
Y. Akasaki y, O. Alvarez-Garcia y, N. Reixach y, J.N. Buxbaum y,
Y. Iwamoto z, M.K. Lotz y. y The Scripps Res. Inst., La Jolla, CA, USA;
zKyushu Univ., Fukuoka, Japan
Purpose: Deposition of amyloid is a common aging-associated phe-
nomenon and a key factor in the pathogenesis of several aging-related
diseases. Osteoarthritis (OA) is the most prevalent joint disease and
aging is its major risk factor. Although amyloid deposits appear to be a
prevalent in OA-affected joints, their composition and effects on cell
and tissue function are unknown. Transthyretin (TTR) is an amyloido-
genic protein. Point mutations in the TTR gene cause of familial amy-
loidotic polyneuropathy and cardiomyopathy. Wild-type TTR can also
assemble into amyloid deposits and this may be facilitated by oxidation,
or the presence of sulfated glycosaminoglycans. This study addressed
TTR deposition in aging and OA-affected knee cartilage and effects of
TTR on chondrocyte function.
Methods: Amyloid deposition in normal and OA human knee cartilage
was determined by Congo-red staining and polarized light microscopy.
TTR in cartilage and synovial ﬂuid was analyzed by immunohis-
tochemistry and western blotting. TTR gene expression in chondrocytes
was studied by quantitative PCR and RNA sequencing. Effects of wild
type and mutant TTR were studied in normal human chondrocyte
cultures with measurements of cell viability and OA-related gene
expression.
Results: There was no amyloid deposition in young normal cartilage. In
contrast, 58% (7/12) of aged normal cartilage and 100% (12/12) of OA
cartilage samples had Congo red staining. TTR was detectable in all OA
and a majority of aged but not in young normal cartilage and pre-
dominantly located at the cartilage surfaces. TTR is not produced by
chondrocytes at substantial levels and synovial ﬂuid levels are similar in
normal and OA affected knees. In chondrocytes, TTR induces cell death,
the expression of proinﬂammatory cytokines and extracellular matrix
degrading enzymes. This was observed for the amyloidogenic but not
for the non-amyloidogenic TTR mutant. Effects of TTR on cell viability
and gene expression are mediated by activation of TLR4 signaling and
MAP kinases. TTR-induced cytotoxicity was inhibited by resveratrol, a
plant polyphenol and the salicylic acid derivate diﬂunisal which both
stabilize the native tetrameric structure of TTR. Studies using transgenic
mice that overexpress wild type human TTR showed that surgically
induced OA was more severe than in wild type mice. In addition, hTTR
transgenic mice also showed more severe spontaneous aging related
OA-like joint changes in cartilage and synovium.
Conclusions: These ﬁndings are the ﬁrst to suggest that TTR amyloid
deposition may not represent an inconsequential aging-related phe-
nomenon but contribute to cell and extracellular matrix damage in
articular cartilage.
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DEVELOPMENTAL SWITCH IN SOX9 EXPRESSION IN ARTICULAR
CARTILAGE IS REGULATED BY EPIGENETIC HISTONE METHYLATION
M. ZHANG, Q. Hua, A. Miller, N. Barnthouse, J. Wang. Univ. of Kansas
Med. Ctr., Kansas City, KS, USA
Purpose:While the role of the SOX9 transcription factor in chondrocyte
differentiation and cartilage formation during skeletal development is
well documented, age-dependent SOX9 expression in articular
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A196chondrocytes (ACs) and its regulatory mechanisms remain unclear. This
study aimed to explore epigenetic regulatory mechanisms of age-rela-
ted SOX9 expression in ACs of mice, spanning from the embryonic stage
to 18 months of age.
Methods: The hip and shoulder joints of wild type BALB/c mice were
harvested at embryonic day 16.5 and 1, 2, 6, 12 and 18 months for
histopathological and immunohistochemical analyses. Femoral and
humeral head cartilage from the same age groups was used for chon-
drocyte isolation, gene expression, methylated DNA immunoprecipita-
tion or chromatin immunoprecipitation assays to examine epigenetic
changes in the promoter region of the Sox9 gene. siRNA-mediated
knockdown of the histone lysine-speciﬁc demethylases-1 gene (Lsd1)
and 5-azacytidine treatment were performed in cultured ACs.
Results: Sox9 mRNA and protein were highly expressed in ACs during
joint development but signiﬁcantly decreased at 2-18 months of age. No
histopathological features of osteoarthritis were observed in examined
joints by 18 months. Epigenetic DNA methylation and histone methyl-
ation are both associated with the age-dependent SOX9 expression.
Knockdown of Lsd1 is sufﬁcient to up-regulate SOX9 expression in ACs of
adult mice through increased recruitment of H3K4me2 (a histone
modiﬁcation for transcriptional activation) in the promoter region of the
Sox9 gene. However, the reduction of DNA methylation in the Sox9
promoter region induced by 5-azacytidine treatment in cultured ACs did
not increase Sox9 expression. The data suggest that reduction of SOX9
expression in ACs of adult mice is primarily regulated by H3K4me2.
Conclusions: These results suggest that SOX9 expression in mouse ACs
is signiﬁcantly decreased after the completion of joint development due
to reduced demands for SOX9. This developmental switch in SOX9
expression in mouse articular cartilage is primarily regulated by epi-
genetic histone methylation.
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NOVEL SUSCEPTABILITY LOCI FOR OSTEOARTHRITIS OF THE HAND:
VARIANTS IN CODING EN GENE REGULATORY REGIONS
C.G. Boer, M. de Kruijf, L. Broer, A. Hofman, A.G. Uitterlinden,
J.J. van Meurs. Erasmus Med. Ctr., Rotterdam, Netherlands
Purpose: Osteoarthritis (OA) of the hand, is to a large extend, genet-
ically determined. However, despite the large GWAS efforts into OA over
the last years only one locus has been found to be associated to hand OA.
We here aim to identify novel genes and pathways involved in the
etiology of hand OA.
Methods: We conducted a genome-wide association study of hand OA
in a discovery set of 10,155 participants from the three Rotterdam Study
cohorts (RS1, RS2 and RS3) using standardized age and gender adjust-
ments. We have used a quantitative bilateral hand OA phenotype,
summing all KL-scores of the hand joints for both hands (min score: 0,
max score: 128). EasyQC was used to conduct quality control across
cohorts. Results were combined in a jointedmeta-analysis using inverse
variance weighting. Genome-wide signiﬁcant signals were analyzes for
enrichment in genomic regulatory regions, using data from the ENCODE
and Roadmap epigenetics project.
Results: The discovery analysis yielded 16 loci with suggestive evidence
for association (P<5*10-6 ) and another 3 loci with genome-wide sig-
niﬁcant association (p<5*10-8). These novel genome-wide signiﬁcant
loci include SNPs in or near the MGP, PTHLH and APBB2 genes. The risk
alleles of MGP, PTHLH and APBB2 genes had a higher KL-sum score
compared to the reference allele (delta KL-score was 7, 6, and 23
respectively) MGP codes for Matrix Gla Protein and is important for
limiting calciﬁcation in tissues. Mutations in the MGP gene have been
associated to Keutel Syndrome, which is characterized by abnormal
mineralization of cartilage tissue. We here identiﬁed a SNP resulting in a
protein-change to be associated with hand OA. The identiﬁed SNPs in
the PTHLH-locus and the APBB2-locus co-localize with enhancer his-
tone markers in osteoblast and chondrogenic cells from the Roadmap
and ENCODE database, suggesting a potential gene regulatory function
for these SNPs.
Conclusions:We identiﬁed 3 loci to be associated to hand OA, a coding
variant in theMPG gene and two intronic variants in APBB2 and CCDC91
located near gene regulatory marks speciﬁc for bone and/or cartilage. In
addition, we have also found 16 loci suggestively associated to hand OA.
Future analysis will consist of validation of our ﬁndings in other cohorts
and further functional assessment and pathway analyses of the iden-
tiﬁed variants310
SMAD3 IS UP-REGULATED IN HUMAN OSTEOARTHRITIC CARTILAGE
INDEPENDENT OF PROMOTER DNA METHYLATION
E. Aref-Eshghi, M. Liu, S.B. Razavi-Lopez, K. Hirasawa, P.E. Harper,
G. Martin, A. Furey, R. Green, P. Rahman, G. Zhai. Mem. Univ. of
Newfoundland, St John's, NL, Canada
Purpose: We previously reported that SMAD3 was associated with the
total burden of radiographic osteoarthritis (OA). SMAD3 is a mediator of
TGF-b signalling pathway that is known to be involved in the cartilage
maintenance and repair. SMAD3 knocked-out mice are deﬁcient for
Collagen and Aggrecan, and develop OA-like features in the joints. The
aim of the present study was to investigate the SMAD3 gene expression
in osteoarthritic and healthy human cartilage and to examine whether
the gene expression is regulated by the promoter DNA methylation.
Methods: Osteoarthritic cartilage samples were collected from patients
who underwent total hip/knee joint replacement surgery due to pri-
mary OA. Healthy cartilage samples were obtained from patients with
hip fracture without any evidence of hip OA. DNA and RNA were
extracted from the cartilage samples using Qiagen’s AllPrep DNA/RNA
Mini Kit. Quantitative PCR experiment was done using ABI-7500 real
time PCR system to measure RNA expression after cDNA synthesis by
ThermoScript cDNA synthesis kit. DNA Methylation was assayed by
Sequonom’s EpiTYPER after DNA bisulphate conversion using Qiagen’s
EpiTect Bisulﬁte Kit. Mann-Whitney test was utilized to examine the
association between OA cases and controls for SMAD3 expression and
its promoter DNA methylation levels. Spearman's rank correlation
analysis was performed to examine the association between the pro-
moter methylation and gene expression. A P-value less than 0.05 was
considered as signiﬁcant.
Results: A total of 49 OA patients (38 hip OA and 11 knee OA) and 51
controls were included in the study. Mean age was 64.4 in OA patients
and 78.7 in controls. Four CpG sites, located ~450bp upstream of the
ﬁrst SMAD3 exon, were assayed, and we found no difference in meth-
ylation between OA cases and controls after adjusting for age. The
expression experiment was performed for 38 patients with OA (32 hips
and 6 knees) and 28 healthy controls, and we found that the SMAD3
gene was expressed in OA cartilage on average 1.8 times higher than
controls (p¼0.0005). Similar results were obtained when we looked at
hip and knee OA separately (p¼0.01). We found no association between
SMAD3 expression and the methylation at the promoter region of the
gene.
Conclusions: Our study demonstrated that SMAD3 is up-regulated in
OA. This up-regulation, however, cannot be explained by the changes in
the promoter DNAmethylation. Given that TGF-b/SMAD3 pathwaymay
play a protective role in the cartilage, the up-regulation of SMAD3 is
more likely due to the consequence of OA, thus reﬂecting repairing
activity stimulated by the cartilage lesion in OA.
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EFFECTS OF HYPOXIA ON ANABOLIC AND CATABOLIC GENE
EXPRESSION AND DNA METHYLATION IN OA CHONDROCYTES
K. Alvarez y, M.C. de Andres y, A. Takahashi y,z, R.O. Oreffo y. yUniv. of
Southampton. Faculty of Med., Southampton, United Kingdom; z Tohoku
Univ. Sch. of Med., Sendai, Japan
Purpose: Osteoarthritis (OA) is a clinical syndrome characterized by
joint pain, functional limitation and reduced quality of life. An essential
feature if the underlying pathogenesis of OA is an imbalance of anabolic
and catabolic activity leading to progressive loss and destruction of
extracellular matrix of articular cartilage. Cartilage is an avascular and
aneural tissue. Chondrocytes thrive in this restricted environment of
low oxygen tension and poor nutrient availability, which has led to
suggestion that hypoxia, may be a protective mechanism against the
development of (OA). There is a growing body of evidence to support
the role of epigenetic factors in the pathogenesis of OA. However, few
studies have investigated the epigenetic-OA process within a hypoxic
environment. The current study has investigated the effects of hypoxia
on gene expression and DNA methylation of anabolic and catabolic
genes involved in the pathogenesis of OA.
Methods: Chondrocytes extracted from OA femoral heads were incu-
bated in normoxia and hypoxia (20% and 2% oxygen concentrations
respectively). Interleukin 1-beta (IL-1b) plus oncostatin M (OSM), 5-
azadeoxycytidine (5-aza-dC) or media alone (control) were added twice
weekly to the incubated samples. After 5 weeks, levels of Collagen type
